These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 10368870)
21. Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats. Riahi E; Mirzaii-Dizgah I; Karimian SM; Sadeghipour HR; Dehpour AR Behav Brain Res; 2009 Jan; 196(1):11-4. PubMed ID: 18634832 [TBL] [Abstract][Full Text] [Related]
22. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice. Fuchs PN; Roza C; Sora I; Uhl G; Raja SN Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835 [TBL] [Abstract][Full Text] [Related]
23. Baclofen reestablishes micro-opioid receptor levels modified by morphine withdrawal syndrome in either sex. Diaz SL; Kemmling AK; Bonavita CD; Rubio MC; Balerio GN Synapse; 2004 Oct; 54(1):24-9. PubMed ID: 15300881 [TBL] [Abstract][Full Text] [Related]
24. Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine. Mundey MK; Mason R; Wilson VG Br J Pharmacol; 1998 Jul; 124(5):911-6. PubMed ID: 9692776 [TBL] [Abstract][Full Text] [Related]
25. Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice. Pedrón VT; Varani AP; Balerio GN Synapse; 2016 May; 70(5):187-97. PubMed ID: 26789010 [TBL] [Abstract][Full Text] [Related]
38. Presynaptic inhibition of GABA(B)-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal. Shoji Y; Delfs J; Williams JT J Neurosci; 1999 Mar; 19(6):2347-55. PubMed ID: 10066284 [TBL] [Abstract][Full Text] [Related]
39. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H. Bot G; Chahl LA; Brent PJ; Johnston PA Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440 [TBL] [Abstract][Full Text] [Related]
40. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro. Feng J; Kendig JJ Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]